SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Ann Richards (HR-ML019)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 1protocol deviations
- 1orders and referrals without results in the record
- 1evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the T-score and FRAX reading (low bone mass with FRAX above threshold, and entering the hand fracture as a previous fracture), the AACE risk category, the drug choice, and the deviation recorded for the late 24-hour urine calcium. |
| provenance review | not_started | | | Recent-death rule: only what Richards made public (her book, interviews, and press coverage) and basic biographical facts are used. Her real T-scores were not found and are not used; her real medicine is not named, and no promotional claim is repeated. The fracture year conflict (1996 or 1994) is recorded. |
| safe messaging review | not_started | | | Alcohol and tobacco claims are marked sensitive; recovery is described in person-first, non-stigmatizing language; the safety assessment records no current risk and gives the 988 Suicide & Crisis Lifeline; her later cancer and death are recorded as history only, without detail. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. Richards died in 2006. The case uses only what she made public herself (her 2003 book as described in reviews, her television interviews, and press coverage of her osteoporosis), her public account of heavy drinking and recovery, and basic biographical facts from state archives and obituaries. No medical records, physician statements, family accounts, or speculation about undisclosed conditions are used. Everything clinical in the modern episode is synthetic: her DXA T-scores, FRAX, laboratory results, vertebral assessment, fall tests, treatment, and preventive care. Claims about alcohol and tobacco are marked sensitive. No sick visit is added.
- Fracture and diagnosis. The sources agree that she broke her hand in a fall and then had a bone density test. CBS News (2003) and the publisher's book description date this to 1996; the Publishers Weekly review dates the hand fracture to 1994. CBS (2003) alone says she fell twice and also broke her ankle. The case uses 1996 with the conflict recorded, and treats the ankle fracture as reported in one source. The published label is osteopenia, “an early stage of osteoporosis”; in some interviews she said she had osteoporosis. Her T-scores were not found in any fetched source (the book itself was not accessed), so none are used.
- Precision in the modern episode. The synthetic T-scores (lumbar spine -2.3, femoral neck -2.0, total hip -1.7) are in the low bone mass range, matching the published osteopenia. The notes say plainly that this is not osteoporosis by T-score and that “early osteoporosis” is not a defined category. Treatment rests on FRAX (22 percent major osteoporotic, 3.6 percent hip, above the 20 and 3 percent thresholds), with her mother's hip fracture (her own public account) and her hand fracture entered. Judgment call: the hand fracture followed a fall from standing height, so it is entered as a previous fracture in FRAX, while the notes explain that a hand fracture does not by itself establish osteoporosis; without it, FRAX would fall below the thresholds. The FRAX values are synthetic estimates, not a recorded calculation from her life. Problem code M85.89 follows the densitometric category; the notes add that AACE 2020 would call this osteoporosis on clinical grounds.
- Drug choice and the spokesperson role. She publicly took a prescription medicine and was a spokesperson for its maker. The record names no brand, does not name or use her medicine, and repeats no promotional claim. The synthetic therapy (zoledronic acid once a year) was chosen strictly by AACE 2020, the Endocrine Society, and BHOF for her synthetic risk (hip risk above threshold, so a drug with proven hip fracture reduction), with once-yearly dosing for her travel. The consultant notes, in general terms, that a selective estrogen receptor modulator is not suitable for a woman whose hip risk is above threshold; this is guideline reasoning about the synthetic patient, not a comment on her real care. Calcium from food, vitamin D, weight-bearing and balance exercise, falls prevention, the secondary-causes work-up, DXA two years after starting, and the drug-holiday rules follow the CMID and the cited guidelines.
- Alcohol use disorder. Her heavy drinking and recovery are public in her own words and in reference biographies (treatment in 1980). The case codes alcohol use disorder in sustained remission (F10.21), so a structured safety assessment was added at intake with the 988 Suicide & Crisis Lifeline, and safety and recovery are reviewed at every later visit; it records no current risk and makes no claim about her real mental health. Who prompted her treatment is not recorded, because the sources attribute it to relatives and friends. Her past heavy smoking is from her own phrase; the quit timing (more than fifteen years before the index visit) is synthetic, and it decides that she is not eligible for lung cancer screening.
- Index age. The modern episode presents Richards at 63, the year after the fall and hand fracture. The synthetic date of birth is September 1, 1962 (shift 29 years). The index visit on February 10, 2026 maps to February 10, 1997; the chronic-care visits on March 10, May 12, and August 11, 2026 map to the same days of 1997; and the adult preventive visit on October 6, 2026 maps to October 6, 1997, when she was 64 (so `preventive_adult`). Every visit falls within her lifetime and after the documented fracture and test. Because she says she had been told of early bone loss after the earlier test and no report is available, the intake DXA serves as a new baseline. The modern record does not model her real treatment after the 1996 test; this is a judgment call for review.
- Synthetic clinical picture. Kept modest: no vertebral fracture, normal secondary-causes tests apart from vitamin D insufficiency (24 ng/mL, corrected to 38), normal mood and alcohol screens, no new falls or fractures. The 2 cm height loss matches the three-quarters of an inch reported in the press. The occupation (public speaker and policy adviser), living situation, diet, menopause timing, and vaccines are synthetic. Her later esophageal cancer and death are recorded as history only and are not used in the episode.
- Focused visits. The three chronic-care follow-ups (four weeks, three months, and six months after intake) are documented as focused visits on the CMID osteoporosis monograph, with AACE 2020, the Endocrine Society, BHOF 2022, and CDC STEADI, and each lists every item the protocol calls for at that point, with its interval and status. The four-week visit is the day of the endocrinology consultation; the three-month visit has the pre-infusion tests and the first zoledronic acid infusion; the six-month visit has the CTX response check three months after the dose. Protocol deviation recorded instead of an invented result: the 24-hour urine calcium ordered at intake was not collected before the four-week visit because she was traveling, and was collected about ten weeks late, before the first dose, with a normal result, no harm, and a corrective action.
- Consultation. The endocrinology referral and the consultation by Marcus Delgado, MD (a fictional consultant), on the day of the four-week visit, are S. The consultant answers all six questions in line with what the record shows happened afterwards: low bone mass with FRAX above threshold (AACE very-high-risk because of the injurious fall and recent fracture); zoledronic acid after vitamin D repletion, a normal calcium and eGFR, and a dental examination; the 24-hour urine collected before the first dose; the balance program; CTX at three months after the dose; DXA two years after starting; and a drug-holiday reassessment after three yearly doses.
- Adult preventive visit. Added on October 6, 2026 (true frame October 6, 1997), at 64. It includes the health risk assessment, a 12-system review, influenza and PCV20 vaccines, a lipid panel with a statin decision, and screening decisions for breast, cervical, colorectal, and lung cancer, diabetes, hepatitis C and HIV, depression, and alcohol. Advance care planning names an unnamed health care agent and records only general priorities (independence and plain information), with no treatment preference, so nothing reads as a claim about her real choices.
- Not used. Her real medicine and its maker, the details of her cancer treatment, her final months, and any family account of her health were not used. The roster's summary was not used as independent evidence.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-03-10 Progress note 02 (C-CDA) | 24-hour urine calcium | At diagnosis, before starting therapy | Ordered at intake to be collected before today; not collected because she was traveling. Deviation from the baseline work-up. No harm so far, because no drug has been started. Corrective action: container and instructions given again, and the result is required before the first infusion |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-03-10 Progress note 02 (C-CDA) | Self-management | Balance and strength exercise program | Referred | Physical therapist program begins next week |
Evidence to check
Retrospective claims (R)
None.
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0003 | D | She spoke openly about her past heavy drinking ("I smoked like a chimney and drank like a fish"), entered treatment, and emerged sober; one biography dates the treatment to 1980 and describes it as successful. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-02-10 | Lumbar spine (L1-L4) T-score | -2.3 (low) | Low |
| 2026-02-10 | Femoral neck T-score | -2 (low) | Low |
| 2026-02-10 | Total hip T-score | -1.7 (low) | Low |
| 2026-02-10 | 25-hydroxyvitamin D | 24 ng/mL (low) | Low |
| 2026-10-06 | Total cholesterol | 204 mg/dL (high) | High |